Laddar...
Recombinant biologic products versus nutraceuticals from plants – a regulatory choice?
Biotechnology has transformed the potential for plants to be a manufacturing source of pharmaceutical compounds. Now, with transgenic and transient expression techniques, virtually any biologic, including vaccines and therapeutics, could be manufactured in plants. However, uncertainty over the regul...
Sparad:
| I publikationen: | Br J Clin Pharmacol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338133/ https://ncbi.nlm.nih.gov/pubmed/27297459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13041 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|